Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer (vol 349, pg 876, 2022)JOURNAL OF CONTROLLED RELEASEIF11.52022-10-010PRE
Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancerJOURNAL OF CONTROLLED RELEASEIF11.52022-09-018PRE
Albumin -conjugated drug is irresistible by single gene mutation of endocytic system: Verification by genome-wide CRISPR-Cas9 loss -of -function screensJOURNAL OF CONTROLLED RELEASEIF11.52020-07-014PRE
KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugsJOURNAL OF CONTROLLED RELEASEIF11.52019-02-0144PREAI
Essential role of cleavage of polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure (vol 104, pg 18688, 2007)PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12008-01-292OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向